Pendleton R G, Gessner G, Weiner G, Jenkins B, Sawyer J, Bondinell W, Intoccia A
J Pharmacol Exp Ther. 1979 Jan;208(1):24-30.
SK&F 29661 is an effective, reversible inhibitor of both central nervous system and adrenal phenylethanolamine N-methyl-transferase in vitro; its Ki values in our standard assay systems were 6 X 10(-7) M (central nervous system) and 3 X 10(-7) M (adrenal), respectively. In vivo, the drug inhibited the conversion of [3H]norepinephrine to [3H]epinephrine in the rat adrenal gland and upon chronic administration decreased the endogenous adrenal epinephrine/norepinephrine ratio in both the rat and squirrel monkey. SK&F 29661 did not, however, reduce rat brain stem PNMT activity after systemic administration; subsequent radioautographic studies indicated that the compound did not enter the central nervous system, presumably because of its high polarity. This drug may be useful in defining the physiological importance of peripheral phenylethanolamine N-methyltransferase inhibition.
SK&F 29661在体外是一种对中枢神经系统和肾上腺苯乙醇胺N-甲基转移酶均有效的可逆抑制剂;在我们的标准检测系统中,其Ki值分别为6×10⁻⁷ M(中枢神经系统)和3×10⁻⁷ M(肾上腺)。在体内,该药物抑制大鼠肾上腺中[³H]去甲肾上腺素向[³H]肾上腺素的转化,长期给药后可降低大鼠和松鼠猴体内肾上腺内源性肾上腺素/去甲肾上腺素的比例。然而,全身给药后SK&F 29661并未降低大鼠脑干的PNMT活性;随后的放射自显影研究表明,该化合物可能因其高极性而未进入中枢神经系统。这种药物可能有助于确定外周苯乙醇胺N-甲基转移酶抑制的生理重要性。